Saypha® VOLUME Lidocaine for Midface Augmentation
Completed · Phase 3
Conditions studied: Moderate to Severe Midface Volume Deficit
In brief
The clinical investigation is a randomized, subject- and evaluator-blinded, active treatment controlled, multicenter, clinical investigation, to demonstrate the non inferiority of saypha® VOLUME Lidocaine to one of the devices approved for the same indication (Juvéderm® Voluma™ XC).
Key facts
- Study ID
- NCT05386030
- Run by
- Croma-Pharma GmbH
- People needed
- 562
- Starts
- 2022-08-16
- Expected to finish
- 2024-12-11
- Last updated by the study team
- 2026-04-09
Who can join
Age: 22 and older, up to 75. Sex: any. Healthy volunteers: accepted.
Where it is running
- Clear Dermatology & Aesthetics Center — Scottsdale, Arizona, United States
- Clinical Testing of Beverly Hills — Encino, California, United States
- Center for Dermatology Cosmetic & Laser Surgery — Fremont, California, United States
- Cosmetic Laser Dermatology — San Diego, California, United States
- About Skin — Greenwood Village, Colorado, United States
- Center for Clinical and Cosmetic Research — Aventura, Florida, United States
- Skin Associates of South Florida — Coral Gables, Florida, United States
- Meridian Clinical Research, Georgia Plastic Surgery — Savannah, Georgia, United States
- Chicago Cosmetic — Chicago, Illinois, United States
- Skin Specialists — Omaha, Nebraska, United States
- Imagedermatology PC — Montclair, New Jersey, United States
- Luxurgery — New York, New York, United States
- DermResearchCenter of NY — Stony Brook, New York, United States
- Aesthetic Solutions — Chapel Hill, North Carolina, United States
- Tennessee Clinical Research Center — Nashville, Tennessee, United States
- DermResearch Inc. Austin — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.